Altea Green Power S.p.A (AGP) Fair Value & Analysis
Technology · IT · Market cap €128M
Fair value as of: Jun 24, 2026
Analysis
Altea Green Power S.p.A (AGP) currently trades at €7.13, while our model-based Fair Value estimate is €8.93 — implying the stock looks roughly 25.2% undervalued today. We read business quality at 95/100 (high quality), in the Technology sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.
About the company
Altea Green Power S.p.A., together with its subsidiaries, supplies and manages renewable energy plants in Italy and the United States. The company engages in the development and building of industrial-scale rooftop and ground-mounted photovoltaic plants, agrivoltaics plant, wind farms, and battery energy storage systems; application of grid connection permits; completion of administrative procedures to obtain functional permits for the implementation of plants; and preliminary and final design and engineering works. It also provides turnkey solutions; energy audit; PPA energy services, revamping, and transfer of surface right of industrial roofs; consulting services; and financing of plant services. The company serves companies, funds, and investors. Altea Green Power S.p.A. was founded in 2008 and is headquartered in Rivoli, Italy.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Altea Green Power S.p.A (AGP) undervalued?
What is the fair value of AGP?
What is the quality score of AGP?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.